Siyan “Stewart” Cao, MD, PhD, Assistant Professor, WashU Medicine Division of Gastroenterology, recently was awarded the 2025 American College of Gastroenterology (ACG) 2025 Clinical Research Award. Four Clinical Research Awards have been awarded to outstanding clinical research in gastroenterology by the American College of Gastroenterology for 2025.
The 2025 Clinical Research award supports a new research project by Dr. Cao that is intended to improve the management of eosinophilic esophagitis (EoE), a chronic inflammatory disease with rising prevalence in the US. The goal is to discover cellular biomarkers that predict response to dupilumab, the first FDA-approved targeted therapy for EoE.
The generous support from ACG allows us to identify novel biomarkers that may help advance personalized management of eosinophilic esophagitis.
Cao shared, “We expect that the findings will enhance patients’ outcomes by identifying individuals who have a good chance to benefit from dupilumab.”
